Melola Discovery

← Melola Discovery

Jurnal SINTA 1

COMPARISON OF PLATELET ANTI AGGREGATION EFFECT ON ACUTE THROMBOTIC STROKE WITH DIABETES MELITUS AND NON-DIBETES MELITUS

Folia Medica Indonesiana · Vol. 49 No. 3 (2013)

ISSN
2355-8393, 2599-056X
Terbit
2013-07-01
Penerbit
Airlangga University
Bahasa
en

Abstrak

Stroke was the highest cause of death and disability of all ages (15.4%) in Indonesia based on RISKESDAS 2007. Thrombotic strokeis one of ischemic stroke that had prevalence of 58.3%. Acetosal/ASA is one of anti-platelet which has been used widely as secondaryprevention for stroke meanwhile, diabetic melitus (DM) was one of the risk factor. Anti-aggregation platelet effect was measured byLight Transmission Aggregometry (LTA). The test had been done twice, before and after ASA usage for 7-10 days. 24 patients thatwere involved, hospitalized for acute thrombotic stroke at least 7-10 days, 15 from non-diabetic group and 9 from diabetic group.The results showed that there is no significant difference in demographic and risk factors for those patients (X2 test, p>0.05). Theaggregation percentage were analyzed statistically by pair t-test for pre-and post-within group, and independent t-test to comparethose two groups. The aggregation percentage of diabetic patients (n=9) was 11-48% (pre) and 7-43% (post). Meanwhile, theaggregation percentage of non-diabetic patients (n=15) was 13-64% (pre) and 13-39% (post). The usage of ASA 1 x 100 mg gave alowering aggregation percentage (t 0,05). It can be concluded that there were no difference on anti-platelet aggregation of ASAbetween diabetic and non diabetic patients with acute thrombotic stroke. For practical purpose, it can be suggested to confirmpercentage aggregation ASA with instrument that applied reliable clinical meaning.(FMI 2013;49 163-167)

Kata kunci

Jaringan kolaborasi para penulis

7 penulis · 9 tautan kepenulisan bersama

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Airlangga
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Nur HadiyantiUniversitas Airlangga1
Didik HasmonoUniversitas Airlangga1
Sunarto ReksoprawiroAfiliasi tidak diketahui1
Ruddy HartonoAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210179714, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">COMPARISON OF PLATELET ANTI AGGREGATION EFFECT ON ACUTE THROMBOTIC STROKE WITH DIABETES MELITUS AND NON-DIBETES MELITUS</dc:title><dc:creator>Adeltrudis Adelsa</dc:creator><dc:creator>Siti Sjamsiah</dc:creator><dc:creator>Mohammad Saiful Islam</dc:creator><dc:subject>platelet aggregation</dc:subject><dc:subject>aspirin</dc:subject><dc:subject>antiplatelet therapy</dc:subject><dc:subject>acute ischemic stroke</dc:subject><dc:subject>thrombotic stroke</dc:subject><dc:subject>diabetes mellitus</dc:subject><dc:subject>light transmission aggregometry</dc:subject><dc:subject>secondary stroke prevention</dc:subject><dc:description xml:lang="en">Stroke was the highest cause of death and disability of all ages (15.4%) in Indonesia based on RISKESDAS 2007. Thrombotic strokeis one of ischemic stroke that had prevalence of 58.3%. Acetosal/ASA is one of anti-platelet which has been used widely as secondaryprevention for stroke meanwhile, diabetic melitus (DM) was one of the risk factor. Anti-aggregation platelet effect was measured byLight Transmission Aggregometry (LTA). The test had been done twice, before and after ASA usage for 7-10 days. 24 patients thatwere involved, hospitalized for acute thrombotic stroke at least 7-10 days, 15 from non-diabetic group and 9 from diabetic group.The results showed that there is no significant difference in demographic and risk factors for those patients (X2 test, p&gt;0.05). Theaggregation percentage were analyzed statistically by pair t-test for pre-and post-within group, and independent t-test to comparethose two groups. The aggregation percentage of diabetic patients (n=9) was 11-48% (pre) and 7-43% (post). Meanwhile, theaggregation percentage of non-diabetic patients (n=15) was 13-64% (pre) and 13-39% (post). The usage of ASA 1 x 100 mg gave alowering aggregation percentage (t 0,05). It can be concluded that there were no difference on anti-platelet aggregation of ASAbetween diabetic and non diabetic patients with acute thrombotic stroke. For practical purpose, it can be suggested to confirmpercentage aggregation ASA with instrument that applied reliable clinical meaning.(FMI 2013;49 163-167)</dc:description><dc:publisher>Airlangga University</dc:publisher><dc:date>2013-07-01</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>http://journal.unair.ac.id/download-fullpapers-fmica49446fa7full.pdf</dc:identifier><dc:source>Folia Medica Indonesiana; Vol 49 No 3 (2013)</dc:source><dc:source>2355-8393</dc:source><dc:source>2599-056X</dc:source><dc:language>en</dc:language></oai_dc:dc>